Literature DB >> 3553628

Leukocytes and the risk of ischemic diseases.

E Ernst, D E Hammerschmidt, U Bagge, A Matrai, J A Dormandy.   

Abstract

Predictive indexes for atherosclerotic risk are imperfect, suggesting that there are predictive factors not commonly considered. Such a factor may be the white blood cell (WBC) count. Epidemiologic studies have shown correlations between the WBC count and the risk of myocardial infarction and stroke. The risk of acute myocardial infarction is approximately four times as great in persons with WBC counts high in the normal range (greater than 9000/microL [9 X 10(9)/L]) as in persons with WBC counts low in the normal range (less than 6000/microL [6 X 10(9)/L]); only 50% to 65% of the excess risk of the high-count individuals is explainable by tobacco smoking (which covaries with WBC count). A high WBC count also predicts greater risk of reinfarction and of in-hospital death. Less rigorously studied, the constitutional neutropenia of Yemenite Jews appears to afford protection against atherosclerotic disease. Among WBC types, the strongest epidemiologic association has been with the neutrophil count. Such a predictive value of WBC count is plausible and satisfying, because WBCs make a major contribution to the rheologic properties of blood; alter adhesive properties under stress--including the stress of ischemia, enhancing their rheologic importance; and participate in endothelial injury, both acutely and chronically, by adhering to endothelium and damaging it with toxic oxygen compounds and proteolytic enzymes. Techniques newly developed or under development may allow us to refine the predictive value of the WBC count by combining it with measures of cell activation and/or activatability.

Entities:  

Mesh:

Year:  1987        PMID: 3553628

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  70 in total

1.  Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

2.  Incidence and risk factors for cardiovascular disease in African Americans with diabetes: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Ayokanmi Adeniyi; Aaron R Folsom; Frederick L Brancati; Moise Desvorieux; James S Pankow; Herman Taylor
Journal:  J Natl Med Assoc       Date:  2002-12       Impact factor: 1.798

3.  Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis.

Authors:  J T Salonen; R Salonen; K Seppänen; M Kantola; S Suntioinen; H Korpela
Journal:  BMJ       Date:  1991-03-30

Review 4.  Lifestyle effects on hematopoiesis and atherosclerosis.

Authors:  Matthias Nahrendorf; Filip K Swirski
Journal:  Circ Res       Date:  2015-02-27       Impact factor: 17.367

Review 5.  Modifiable Cardiovascular Risk, Hematopoiesis, and Innate Immunity.

Authors:  Maximilian J Schloss; Filip K Swirski; Matthias Nahrendorf
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

6.  Dietary behaviour and health in Northern Ireland: an exploration of biochemical and haematological associations.

Authors:  M E Barker; S I McClean; J J Strain; K A Thompson
Journal:  J Epidemiol Community Health       Date:  1992-04       Impact factor: 3.710

7.  Elevations in preoperative monocyte count predispose to acute neurocognitive decline after carotid endarterectomy for asymptomatic carotid artery stenosis.

Authors:  J Mocco; David A Wilson; Andrew F Ducruet; Ricardo J Komotar; William J Mack; Joseph Zurica; Robert R Sciacca; Eric J Heyer; E Sander Connolly
Journal:  Stroke       Date:  2005-12-01       Impact factor: 7.914

Review 8.  Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders.

Authors:  K J Palmer; K L Goa
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

Review 9.  Lethal limb ischaemia in leukaemia. Case report and review of the literature.

Authors:  Cristina Belizna; Marc Antoine Pistorius; Bernard Planchon
Journal:  J Thromb Thrombolysis       Date:  2008-10-11       Impact factor: 2.300

10.  White blood cell count and the occurrence of silent ischemia after myocardial infarction.

Authors:  Małgorzata Kurpesa; Ewa Trzos; Maria Krzemińska-Pakuła
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-01       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.